Last updated on July 2018

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL STUDY TO ASSESS THE SAFETY AND EFFICACY OF PULSED, INHALED NITRIC OXIDE (iNO) IN SUBJECTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH PULMONARY FIBROSIS ON LONG TERM OXYGEN THERAPY


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pulmonary Fibrosis | Pulmonary/Respiratory Diseases
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

  • Diagnosed with pulmonary fibrosis by high resolution CT
  • Have been using oxygen therapy by nasal cannula for at least 4 weeks prior to the screening run-in period.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.